AusperBio | Biotech & Life Sciences | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/AusperBio

Company Overview Backed By Recent Activity Similar Companies Startup DNA

AusperBio

A clinical stage biopharmaceutical company focused on developing targeted oligonucleotide therapeutics for chronic diseases, particularly chronic hepatitis B virus (HBV) infection

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical development

Model

01Company Overview

A clinical stage biopharmaceutical company focused on developing targeted oligonucleotide therapeutics for chronic diseases, particularly chronic hepatitis B virus (HBV) infection.

02Backed By2 investors

CICDH Investments→HCHankang Capital→

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

Recent Activity

FROM Hankang Capital

Participated as an existing investor in AusperBio's $120M Series C financing to advance chronic Hepatitis B functional-cure therapy AHB-137.

INVESTMENT·biospace.com+1

AUG 27, 2026

FROM Hankang Capital

Participated in AusperBio's $50M Series B+ financing round alongside Sherpa Capital.

INVESTMENT·ausperbio.com

MAY 2025

04Similar Companies

P

PepGen

Biotech & Life Sciences

→

AP

ADARx Pharmaceuticals

Biotech & Life Sciences

→

NT

nLife Therapeutics

Biotech & Life Sciences

→

OH

Oak Hill Bio

Biotech & Life Sciences

→

A

Alumis

Biotech & Life Sciences

→

05Startup DNA

signals

Sectors
Business Model
Technology

Quick Reference

Sector

Biotech & Life Sciences · Healthcare & Digital Health